Nuo Therapeutics Inc Stock OTC Bulletin Board
Equities
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
Apr. 19 | Nuo Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mar. 19 | Exor-backed NUO invests in Italian teenage clothing chain Subdued | RE |
Financials (USD)
Sales 2021 | - | Sales 2022 | 112K | Capitalization | 62.7M |
---|---|---|---|---|---|
Net income 2021 | - | Net income 2022 | -3M | EV / Sales 2021 | - |
Net cash position 2021 | 1.41M | Net cash position 2022 | 1.72M | EV / Sales 2022 | 543 x |
P/E ratio 2021 |
-
| P/E ratio 2022 |
-18.9
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 36.55% |
Managers | Title | Age | Since |
---|---|---|---|
David Jorden
CEO | Chief Executive Officer | 61 | 08-09-18 |
Peter Clausen
COO | Chief Operating Officer | 58 | 08-08-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
C. Eric Winzer
BRD | Director/Board Member | 67 | 09-01-29 |
David Jorden
CEO | Chief Executive Officer | 61 | 08-09-18 |
Paul D. Mintz
BRD | Director/Board Member | 75 | 17-04-06 |
1st Jan change | Capi. | |
---|---|---|
-3.10% | 102B | |
+2.11% | 96.07B | |
-1.80% | 21.66B | |
-17.75% | 20.77B | |
-6.91% | 18.53B | |
-42.00% | 16.91B | |
-28.19% | 13.79B | |
+0.18% | 13.33B | |
+19.90% | 10.94B |